Endoscopic Antral Myotomy for Weight Loss
Official title: Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure: A Pilot Study
Run by Brigham and Women's Hospital · NCT05711758 · Data updated 2026-11-12
This study is testing a new weight loss procedure called Pylorus Sparing Antral Myotomy to see if it helps people with obesity lose weight safely and effectively on its own.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Brigham and Women's Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | September 22, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT05711758 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 with a BMI greater than 35 kg/m2 who are eligible for endoscopic and surgical weight loss procedures.
✕Probably not a fit
Patients with untreated H. pylori infection, active smoking habits, or a history of certain gastrointestinal conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the efficacy and safety of the Pylorus Sparing Antral Myotomy (PSAM) technique as a standalone weight loss procedure. PSAM aims to delay gastric emptying to promote weight loss while minimizing procedure time and adverse events. The study will involve patients with obesity who are eligible for endoscopic and surgical weight loss procedures, assessing their safety, tolerability, and short-term efficacy. This approach is novel as it investigates PSAM independent of other interventions like endoscopic sleeve gastroplasty (ESG).
Why it matters
Potential benefit: If successful, this procedure could provide a new, effective option for weight loss in patients with obesity.
How similar studies have gone: While PSAM has been previously combined with ESG, this study is novel as it evaluates PSAM alone, with no prior clinical studies investigating its efficacy independently.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects must be 18-70 years of age * eligible for endoscopic and surgical weight loss procedures * body mass index (BMI) greater than 35 kg/m2 * Individuals must be in excellent mental health * able to understand and sign informed consent * available to return for all routine follow-up study visits Exclusion Criteria: * untreated H. pylori infection * gastroparesis * active smoking * an ongoing or a history of treatment with opioids in the last 12 months prior to enrollment * previous pyloromyotomy or pyloroplasty * gastrointestinal obstruction * severe coagulopathy * esophageal or gastric varices and/or portal hypertensive gastropathy * pregnancy or puerperium * any inflammatory disease of the gastrointestinal tract (including but not limited to severe (LA Grade C or D) esophagitis, active gastric ulceration, active duodenal ulceration, or specific inflammation such as Crohn's disease) * malignant or premalignant gastric diseases (such as high grade dysplasia, gastric cancer, or GIST) * severe cardiopulmonary disease or a history of coronary artery disease (including myocardial infarction within the past 6 months, poorly controlled hypertension, required use of NSAIDs) * lactation * history of gastrointestinal surgery * any serious health condition unrelated to their weight that would increase the risk of endoscopy * chronic abdominal pain * active psychological issues preventing participation in a lifestyle modification program * a known history of endocrine disorders affecting weight (uncontrolled hypothyroidism) * an inability to provide informed consent * use of any medication that may interfere with weight loss * use of any medication that may interfere with gastric emptying * any other condition which the investigator may deem as an impediment to compliance or hinder completion of the proposed study
Where it's running
-
Brigham and Women's Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Christopher C. Thompson, MD, MSc — Brigham and Women's Hospital
- Study coordinator: Michele B. Ryan, MS
- Email: mryan@bwh.harvard.edu
- Phone: 6176765928
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Endoscopic treatment for overweight and mild obesity using Orbera365
This study is testing whether the Orbera365 intragastric balloon can help people who are overweight or mildly obese lose weight over a year.
-
Comparing conventional and tailored limb lengths in gastric bypass surgery
This study is testing whether customizing the lengths of certain parts of gastric bypass surgery can help people lose more weight and improve their health compared to standard lengths.
-
Adding naltrexone–bupropion extended‑release to sleeve gastrectomy to improve weight loss
This trial will test whether taking naltrexone–bupropion extended‑release after sleeve gastrectomy helps adults with obesity lose more weight and improve related health problems.
-
Using a new endoscopy technique for bariatric patients
This study is testing a new, less invasive endoscopy method for bariatric patients to see if it can improve safety and reduce costs when checking for stomach and digestive issues.
-
Endoscopic sleeve gastroplasty for people with obesity and MASH
This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.
-
Understanding how metabolism and inflammation affect diabetes in teens
This study is trying to see how body weight, lifestyle, and diet affect inflammation and metabolism in teens to better understand diabetes risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.